Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Tumor Necrosis Factor-α
100%
Cytokine Production
100%
Lymphoid Cells
100%
Cellular Immunotherapy
100%
Interleukin-2
83%
Interferon-α (IFN-α)
66%
Non-responders
66%
Peripheral Blood Mononuclear Cells
50%
Supernatant
33%
Peripheral Blood Lymphocytes
33%
Lymphokine-activated Killer Cells
33%
No Significant Difference
16%
Cell Population
16%
Cell Function
16%
CD3+
16%
Host Response
16%
Cell Culture
16%
High Concentration
16%
Monocytes
16%
Immune System
16%
Response Group
16%
Adoptive Immunotherapy
16%
Immunological Parameters
16%
Immunotherapy Trials
16%
Stimulants
16%
Patients with Advanced Cancer
16%
CD14+CD16+
16%
CD22
16%
Dose-dependent
16%
Cells Supernatant
16%
Linear Association
16%
Immunology and Microbiology
Immunotherapy
100%
Innate Lymphoid Cell
100%
Cytokine Production
100%
Tumor Necrosis Factor Alpha
85%
Interleukin 2
71%
interferon
57%
Supernatant
42%
Peripheral Blood Mononuclear Cell
42%
Peripheral Blood Lymphocyte
28%
Lymphokine Activated Killer Cell
28%
Secretion (Process)
14%
Immune Response
14%
Monocyte
14%
Cell Function
14%
Cell Culture
14%
CD16
14%
Cell Subpopulation
14%
CD22
14%
Immune System
14%
CD3 Antigen
14%
In Vitro
14%